← Leaderboards
Robert S Kerbel
Sunnybrook &Women'S Coll Hlth Scis Ctr
$2,445,170
Attributed
$2,445,170
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $203K · FY2005–13$250K$187.5K$125K$62.5K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
Funding mix
By agency
NIH$2,445,170 · 1
By mechanism
R01$2,445,170 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Angiogenesis”
- David Heimbrook · Leidos Biomedical Research, Inc.$75,067,502
- Steven Terry Rosen · Beckman Research Institute/City Of Hope$59,567,306
- Martin Friedlander · Scripps Research Institute$48,350,175
- Larry Arthur$33,866,306
- Michael Simons · Yale University$30,647,106
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$29,372,588
Research focus
AngiogenesisVascular Endothelial Growth FactorsAngiogenesis InhibitorsTransposon /Insertion ElementNeoplasm /Cancer GeneticsInterleukin 6Neoplasm /Cancer Blood SupplyTissue /Cell CultureAthymic MouseMediatingHost Neoplasm InteractionAntibodiesAdverse EffectsMalignant NeoplasmsChemotherapy-Oncologic ProcedureMelanomaDoseBaseDesignDrug CombinationsAcuteCellsBone MarrowChemotherapy
Grant awards (13)
Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy$180,805
R01 · FY2013 · CA · contact PI
Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy$192,346
R01 · FY2012 · CA · contact PI
Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy$192,346
R01 · FY2011 · CA · contact PI
Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy$198,294
R01 · FY2010 · CA · contact PI
Host Cell Assisted Primary and Metastatic Tumor Regrowth after Chemotherapy$198,294
R01 · FY2009 · CA · contact PI
Exploiting Angiogenesis for Induction of Tumor Dormancy$192,519
R01 · FY2007 · CA · contact PI
Exploiting Angiogenesis for Induction of Tumor Dormancy$198,269
R01 · FY2006 · CA · contact PI
Exploiting Angiogenesis for Induction of Tumor Dormancy$203,040
R01 · FY2005 · CA
Exploiting Angiogenesis for Induction of Tumor Dormancy$203,040
R01 · FY2004 · CA
Exploiting Angiogenesis for Induction of Tumor Dormancy$203,040
R01 · FY2003 · CA
DORMANCY VERSUS PROGRESSION OF HUMAN PRIMARY MELANOMA$165,843
R01 · FY2002 · CA
DORMANCY VERSUS PROGRESSION OF HUMAN PRIMARY MELANOMA$161,012
R01 · FY2001 · CA
DORMANCY VERSUS PROGRESSION OF HUMAN PRIMARY MELANOMA$156,322
R01 · FY2000 · CA